KOR

e-Article

EBSCO Discovery Service
Publication date
-
(ex : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'e-Article' searched 546results | List 1~20
Academic Journal
Coombs CC; University of California Irvine, Irvine, CA, USA.; Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Brown JR; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Ghia P; Universita Vita-Salute San Raffaele Milano, Milano, Italy.; IRCCS Ospedale San Raffaele, Milano, Italy.; Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Patel K; Swedish Cancer Institute, Seattle, WA, USA.; Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, UK.; Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Seymour JF; Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.; Shah NN; Medical College of Wisconsin, Milwaukee, WI, USA.; Flinn I; Sarah Cannon Research Institute/Tennessee Oncology/OneOncology, Nashville, TN, USA.; Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, WA, Australia.; Ma S; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Rhodes JM; Rutgers Cancer Institute, New Brunswick, NJ, USA.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.; Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.; Wierda WG; MD Anderson Cancer Center, Houston, TX, USA.; Hess LM; Eli Lilly and Company, Indianapolis, IN, USA.; Bhandari NR; Eli Lilly and Company, Indianapolis, IN, USA.; Loubert A; Modus Outcomes, Lyon, France.; Abada PB; Eli Lilly and Company, Indianapolis, IN, USA.; Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New Year, NY, USA.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE
Editorial & Opinion
Tantawy SI; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Internal Medicine Department, College of Medicine, Suez Canal University, Ismailia, Egypt.; Aslan B; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Manyam G; Department of Bioinformatics and Computer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iles LR; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Timofeeva N; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Singh N; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thompson PA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Desikan SP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gandhi V; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vgandhi@mdanderson.org.; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vgandhi@mdanderson.org.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Academic Journal
Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.; Grosicki S; Department of Cancer Prevention, Medical University of Silesia, Katowice, Poland.; Wrobel T; Department of Hematology, Cellular Therapies and Internal Medicine, Medical University of Wroclaw, Wroclaw, Poland.; Capra M; Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil.; Czyz J; Departament of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Torun, Poland.; Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.; Eom KS; Department of Hematology, Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South).; Panovská A; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Jurczak W; Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.; Laribi K; Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France.; Jacobasch L; Praxis of Haematology and Oncology, Dresden, Germany.; Baker R; Perth Blood Institute, Perth, WA, Australia.; Agajanian R; The Oncology Institute of Hope and Innovation, Whittier, CA.; Berkovits A; Inmunocel, Santiago, Chile.; Özcan M; Ankara University, School of Medicine, Ankara, Turkey.; Lepretre S; Centre de Lutte Contre le Cancer-Centre Henri Becquerel Normandie Rouen, Rouen, France.; Coombs CC; University of California Irvine, Irvine, CA.; Cramer P; Department of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.; Lewis KL; Division of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; Division of Internal Medicine, Medical School, University of Western Australia, Perth, WA, Australia.; Hill M; Eli Lilly and Company, Indianapolis, IN.; Bao K; Eli Lilly and Company, Indianapolis, IN.; Bian Y; Eli Lilly and Company, Indianapolis, IN.; De Batista Ribeiro SR; Eli Lilly and Company, Indianapolis, IN.; Bhandari NR; Eli Lilly and Company, Indianapolis, IN.; Ruppert AS; Eli Lilly and Company, Indianapolis, IN.; Leow CC; Eli Lilly and Company, Indianapolis, IN.; Wierda WG; University of Texas MD Anderson Cancer Center, Houston, TX.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Swaminathan M; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Ferrajoli A; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Thompson PA; Peter MacCallum Cancer Centre Melbourne Australia.; Burger J; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Borthakur G; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Takahashi K; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Estrov Z; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Bharathi V; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Bataller A; The University of Texas MD Anderson Cancer Center Houston United States.; Kadia TM; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Pemmaraju N; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Daver N; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Jabbour E; Department of Leukemia, University of Texas MD Anderson Cancer Center Houston, TX United States.; Bose P; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Kanagal-Shamanna R; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Patel KP; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Wang SA; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Garg N; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Hwang H; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Wang X; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Qiao W; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Xu X; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Cruz N; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Ayala A; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Pierce S; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Plunkett W; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Sampath D; The University of Texas MD Anderson Cancer Center Houston United States.; Kantarjian HM; The University of Texas MD Anderson Cancer Center Houston, Tx United States.; Keating MJ; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Gandhi V; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Wierda WG; The University of Texas MD Anderson Cancer Center Houston, TX United States.; Jain N; The University of Texas MD Anderson Cancer Center Houston, TX United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Refining the search results
Facets
[AR] Wierda, William G
Publication year
-
Database provider
Title
Publisher
자료유형(Source Type)
Subject
Language